Literature DB >> 8622656

Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network.

M Jeffers1, S Rong, G F Vande Woude.   

Abstract

Hepatocyte growth factor/scatter factor (HGF/SF) is a pleiotropic effector of cells expressing the Met tyrosine kinase receptor. Although HGF/SF is synthesized by mesenchymal cells and acts predominantly on epithelial cells, we have recently demonstrated that human sarcoma cell lines often inappropriately express high levels of Met and respond mitogenically to HGF/SF. In the present report we show that HGF/SF-Met signalling in the human leiomyosarcoma cell line SK-LMS-1 enhances its in vivo tumorigenicity, an effect for which the mitogenicity of this signalling pathway is likely to play a role. In addition, we found that HGF/SF-Met signalling dramatically induces the in vitro invasiveness and in vivo metastatic potential of these cells. We have studied the molecular basis by which HGFSF-Met signalling mediates the invasive phenotype. A strong correlation has previously been demonstrated between the activation of the urokinase plasminogen activator (uPA) proteolysis network and the acquisition of the invasive-metastatic phenotype, and we show here that HGF/SF-Met signalling significantly increases the protein levels of both uPA and its cellular receptor in SK-LMS-1 cells. This results in elevated levels of cell-associated uPA and enhanced plasmin-generating ability by these cells. These studies couple HGF/SF-Met signalling to the activation of proteases that mediate dissolution of the extracellular matrix-basement membrane, and important property for cellular invasion-metastasis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8622656      PMCID: PMC231094          DOI: 10.1128/MCB.16.3.1115

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

1.  Hepatocyte growth factor/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epithelium.

Authors:  A Nusrat; C A Parkos; A E Bacarra; P J Godowski; C Delp-Archer; E M Rosen; J L Madara
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

2.  Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation.

Authors:  S Rong; S Segal; M Anver; J H Resau; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

3.  Involvement of hepatocyte growth factor in kidney development.

Authors:  O F Santos; E J Barros; X M Yang; K Matsumoto; T Nakamura; M Park; S K Nigam
Journal:  Dev Biol       Date:  1994-06       Impact factor: 3.582

4.  Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts.

Authors:  G De Petro; A Copeta; S Barlati
Journal:  Exp Cell Res       Date:  1994-07       Impact factor: 3.905

5.  Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor.

Authors:  Y Uehara; O Minowa; C Mori; K Shiota; J Kuno; T Noda; N Kitamura
Journal:  Nature       Date:  1995-02-23       Impact factor: 49.962

6.  Scatter factor/hepatocyte growth factor is essential for liver development.

Authors:  C Schmidt; F Bladt; S Goedecke; V Brinkmann; W Zschiesche; M Sharpe; E Gherardi; C Birchmeier
Journal:  Nature       Date:  1995-02-23       Impact factor: 49.962

7.  Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta.

Authors:  L E Odekon; F Blasi; D B Rifkin
Journal:  J Cell Physiol       Date:  1994-03       Impact factor: 6.384

8.  An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II.

Authors:  K A Hajjar; A T Jacovina; J Chacko
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

9.  An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation.

Authors:  G M Cesarman; C A Guevara; K A Hajjar
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

10.  Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros.

Authors:  A S Woolf; M Kolatsi-Joannou; P Hardman; E Andermarcher; C Moorby; L G Fine; P S Jat; M D Noble; E Gherardi
Journal:  J Cell Biol       Date:  1995-01       Impact factor: 10.539

View more
  82 in total

Review 1.  Roles of hepatocyte growth factor/scatter factor and transforming growth factor-beta1 in mammary gland ductal morphogenesis.

Authors:  J V Soriano; M S Pepper; L Orci; R Montesano
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

2.  Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line.

Authors:  S Yi; M S Tsao
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

3.  Induction of c-met proto-oncogene expression at the metastatic site.

Authors:  J Imai; M Watanabe; M Sasaki; R Yamaguchi; S Tateyama; S Sugano
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

4.  Activating mutations for the met tyrosine kinase receptor in human cancer.

Authors:  M Jeffers; L Schmidt; N Nakaigawa; C P Webb; G Weirich; T Kishida; B Zbar; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

5.  Construction of human naïve Fab library and characterization of anti-met Fab fragment generated from the library.

Authors:  Yongjun Jiao; Ping Zhao; Jin Zhu; Tessa Grabinski; Zhengqing Feng; Xiaohong Guan; R Scot Skinner; Milton D Gross; Rick V Hay; Hiroshi Tachibana; Brian Cao
Journal:  Mol Biotechnol       Date:  2005-09       Impact factor: 2.695

6.  The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.

Authors:  Luis J Herrera; Talal El-Hefnawy; Pierre E Queiroz de Oliveira; Siva Raja; Sydney Finkelstein; William Gooding; James D Luketich; Tony E Godfrey; Steven J Hughes
Journal:  Neoplasia       Date:  2005-01       Impact factor: 5.715

7.  Coordinate integrin and c-Met signaling regulate Wnt gene expression during epithelial morphogenesis.

Authors:  Yingjie Liu; Nibedita Chattopadhyay; Shan Qin; Charles Szekeres; Tetyana Vasylyeva; Zhen X Mahoney; Mary Taglienti; Carlton M Bates; Harold A Chapman; Jeffrey H Miner; Jordan A Kreidberg
Journal:  Development       Date:  2009-01-28       Impact factor: 6.868

8.  Knockdown of c-MET induced apoptosis in ABCB1-overexpressed multidrug-resistance cancer cell lines.

Authors:  T-H Hung; Y-H Li; C-P Tseng; Y-W Lan; S-C Hsu; Y-H Chen; T-T Huang; H-C Lai; C-M Chen; K-B Choo; K-Y Chong
Journal:  Cancer Gene Ther       Date:  2015-04-24       Impact factor: 5.987

Review 9.  MET targeted therapy for lung cancer: clinical development and future directions.

Authors:  Yan Feng; Patrick C Ma
Journal:  Lung Cancer (Auckl)       Date:  2012-08-09

10.  Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation.

Authors:  Yu-Wen Zhang; Yanli Su; Olga V Volpert; George F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.